Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2780 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-SERTRALINE | 100MG | CAPSULE | Resolved | 2019-05-29 | 2020-03-02 | 85161 |
APO-OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-11-27 | 2020-03-02 | 99792 |
APO-INDAPAMIDE 1.25 MG TABLETS | 1.25MG | TABLET | Resolved | 2019-09-25 | 2020-03-02 | 94740 |
APO-HYDRALAZINE | 50MG | TABLET | Resolved | 2020-01-29 | 2020-02-28 | 104694 |
APO-NAPROXEN | 250MG | TABLET | Resolved | 2020-02-13 | 2020-02-28 | 106003 |
APO-LAMIVUDINE HBV | 100MG | TABLET | Resolved | 2019-12-05 | 2020-02-25 | 100278 |
APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2020-02-05 | 2020-02-25 | 105333 |
APO-CANDESARTAN | 8MG | TABLET | Resolved | 2017-08-08 | 2020-02-25 | 18520 |
APO-CANDESARTAN | 4MG | TABLET | Resolved | 2017-08-08 | 2020-02-25 | 18517 |
APO-CANDESARTAN | 32MG | TABLET | Resolved | 2017-03-20 | 2020-02-25 | 3516 |
APO-CANDESARTAN | 16MG | TABLET | Resolved | 2018-01-03 | 2020-02-25 | 34838 |
APO-NAPROXEN | 375MG | TABLET | Resolved | 2020-01-22 | 2020-02-21 | 103914 |
APO-NAPROXEN | 375MG | TABLET | Resolved | 2020-02-05 | 2020-02-21 | 105352 |
APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2019-08-28 | 2020-02-19 | 92522 |
APO-CARBAMAZEPINE | 200MG | TABLET | Resolved | 2017-08-11 | 2020-02-19 | 18766 |
APO-AMOXI CLAV | 250MG 125MG | TABLET | Resolved | 2020-01-15 | 2020-02-19 | 103357 |
APO-ACYCLOVIR OINTMENT | 5% | OINTMENT | Resolved | 2020-01-08 | 2020-02-19 | 102523 |
APO-CEFEPIME | 2G | POWDER FOR SOLUTION | Resolved | 2019-12-05 | 2020-02-18 | 100265 |
APO-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2020-02-05 | 2020-02-18 | 105348 |
APO-LATANOPROST | 50MCG | SOLUTION | Resolved | 2017-03-10 | 2020-02-13 | 363 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2018-09-08 | 2019-03-29 | 60720 |
APO-DOCUSATE SODIUM | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2019-03-29 | 40733 |
APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |
APO-NEVIRAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-03-11 | 2019-03-11 | 78257 |
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
APO-CEPHALEX | 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-21 | 60370 |
APO-CEFPROZIL | 250MG | TABLET | Discontinued | 2019-01-04 | 2019-02-21 | 71195 |
APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-02-21 | 70802 |
APO-DICLOFENAC OPHTHALMIC | 0.1% | SOLUTION | Discontinued | 2018-09-07 | 2019-02-13 | 60426 |
APO-TADALAFIL | 20MG | TABLET | Discontinued | 2018-09-10 | 2019-02-13 | 61045 |
APO-DONEPEZIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60453 |
APO TRIAZIDE | 50MG 25MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60837 |
APO-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60769 |
APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60763 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
APO-LISINOPRIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60585 |
APO-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60521 |
APO-CITALOPRAM | 20MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60393 |
APO-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60279 |